We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Awards & Recognition
Paul, Weiss Shortlisted in Six Categories for LMG Life Sciences Americas Awards
Paul, Weiss is shortlisted in six categories in LMG Life Sciences’ 2022 LMG Life Sciences Americas Awards. The firm is a contender for “General Patent Litigation Firm of the Year.”
» moreEvents
Megan Raymond to Model Argument For Participants in USPTO Legal Experience and Advancement Program Mock AIA Trial
Litigation counsel Megan Raymond will present an argument in “America Invents Act (AIA) Oral Argument Encore,” hosted by the USPTO’s Legal Experience and Advancement Program (LEAP).
» moreClient News
Genentech Wins Summary Judgment in Patent Dispute Over Hemophilia A Drug
See Also
Paul, Weiss won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough hemophilia treatment HEMLIBRA® (emicizumab).
» moreEvents
Nick Groombridge and Jennifer H. Wu to Discuss Vaccine Waivers and Section 101 at Federal Circuit Bar Association Event
Litigation partners Nick Groombridge and Jennifer H. Wu will participate in the Federal Circuit Bar Association’s “2022 Global Series Spring Session” event.
» morePublications
Intellectual Property Litigation: Recent Cases Address the Copyright Act’s Termination Right
Litigation partners Eric Stone and Catherine Nyarady’s latest intellectual property litigation column, “Recent Cases Address the Copyright Act’s Termination Right,” appeared in the July 13 issue of the New York Law Journal.
» moreAwards & Recognition
Paul, Weiss Life Sciences Practice Named Law360 “Practice Group of the Year”
Paul, Weiss won Law360 “Practice Group of the Year” recognition for its achievements in 2021 in the Life Sciences category.
» moreEvents
Jennifer H. Wu to Moderate PLI Panel on Artificial Intelligence and Data-Driven Business Models
See Also
Litigation partner Jennifer H. Wu will moderate a panel, “Eliminating Bias in AI and Data-Centric Business Models and Ecosystems.”
» moreAwards & Recognition
Megan Raymond and Paul, Weiss Recognized by PTAB Bar Association
Litigation counsel Megan Raymond was named to the PTAB Bar Association’s “Top 50 Women in PTAB Trials” list.
» moreAwards & Recognition
Paul, Weiss and Nick Groombridge Are Finalists in LMG Life Sciences 2021 Awards
Paul, Weiss and litigation partner Nick Groombridge are 2021 finalists in the Legal Media Group (LMG) Life Sciences 2021 Awards.
» moreClient News
Chugai Pharmaceutical Secures Victory in Patent Appeals
See Also
Paul, Weiss secured an appellate victory for Tokyo-based drug manufacturer Chugai Pharmaceutical Co. Ltd in a dispute regarding two Chugai patents for a simpler, less costly method of purifying antibodies.
» moreAwards & Recognition
Nick Groombridge, Steve Baughman and David Ball Named IAM Global Leaders 2022
Litigation partners Nick Groombridge and Steve Baughman and of counsel David Ball were included in IAM Global Leaders 2022, a publication of IAM.
» moreClient News
Edwards Lifesciences Wins Court Victory in Patent Dispute Over Heart Valve Repair Device
See Also
Paul, Weiss won a significant victory for Edwards Lifesciences in patent litigation brought by Abbott Laboratories concerning Edwards’ PASCAL, an important new medical device recently approved for use in Europe to treat a common form of often-fatal heart disease called mitral regurgitation.
» moreAwards & Recognition
Steve Baughman Named President-Elect of the PTAB Bar Association
Litigation partner Steve Baughman was named President-Elect of the PTAB Bar Association following the organization’s annual meeting on March 28, 2019.
» moreClient News
Paul, Weiss Obtains Federal Circuit Affirmance of PTAB Win Against Rosetta-Wireless
See Also
Paul, Weiss secured a win in the U.S. Court of Appeals for the Federal Circuit for our client, a leading consumer electronics company, against Rosetta Wireless.
» moreClient News
Landmark Decision for Vanda Affirms That Innovations in Treatment Can Be Patented
See Also
Paul, Weiss secured a major appellate victory on behalf of Vanda Pharmaceuticals Inc. before the U.S. Court of Appeals for the Federal Circuit.
» more